DISEASE INDICATIONS: Asthma

MANUFACTURER: Amgen / AstraZeneca AB

USAGE: Subcutaneous

MEDICINE APPROVED BY:

Food and Drug Administration (FDA)

Tezspire (tezepelumab-ekko) is a medication prescribed as an add-on maintenance treatment for individuals aged 12 years and older, both adult and pediatric, with severe asthma.